InvestorsHub Logo

piggerpig

10/25/10 11:27 AM

#2760 RE: JJM760 #2759

dont sweat it

TetonBill

10/25/10 11:27 AM

#2761 RE: JJM760 #2759

My impression was that they were referring to the side effects of the drug in the headline. But the text indicated that the side effects were common in drugs of this kind and not unexpected.

mrplmer

10/25/10 11:28 AM

#2762 RE: JJM760 #2759

Welcome to a fixed game! Written by a proxy for somebody onthe Short side.

BTH

10/25/10 11:31 AM

#2763 RE: JJM760 #2759

Reuters has people in Bangladesh and interns at their HQ in NYC picking up the full story and trying to make a headline out of it. These guys are not biotech people, and have no business trying to make a full research story out of what Ariad just announced.

There is no bad news here. Anyone who knows mTOR knows these are the side-effects. Just like the miserable side-effects of the multi-billion dollar drug, Avastin.

Wonder when Jonny Come Lately, JPMorgan and the others will be printing their updated "research reports". (too bad they didn't read these forums or they could have made 20% for their clients today - traded as high as 4.80 pre-market).





lax20m

10/25/10 12:14 PM

#2766 RE: JJM760 #2759

The "mixed" part from the article is the increase in the side effects. I agree that the headline seems misleading.